2012
DOI: 10.1097/aog.0b013e3182699a15
|View full text |Cite
|
Sign up to set email alerts
|

Progestogens for Preterm Birth Prevention

Abstract: Progestogens prevent preterm birth when used in singleton pregnancies for women with a prior preterm birth. In contrast, evidence suggests lack of effectiveness for multiple gestations. Evidence supporting all other uses is insufficient to guide clinical care. Overall, clinicians and patients lack longer-term information to understand whether intervention has the ultimately desired outcome of preventing morbidity and promoting normal childhood development.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
15
0

Year Published

2013
2013
2020
2020

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 38 publications
(15 citation statements)
references
References 46 publications
0
15
0
Order By: Relevance
“…There is no fully effective agent for prevention of PTL. Progesterone (P4) to maintain uterine quiescence, and cervical cerclage to prevent premature CR have some efficacy in terms of reducing PTB, but there is little evidence of long-term beneficial effects for the baby (Alfirevic et al , 2012; Likis et al , 2012). Similarly, short term, but not long-term, benefits were demonstrated in a recent network analysis of tocolytics (Haas et al , 2012).…”
Section: Introductionmentioning
confidence: 99%
“…There is no fully effective agent for prevention of PTL. Progesterone (P4) to maintain uterine quiescence, and cervical cerclage to prevent premature CR have some efficacy in terms of reducing PTB, but there is little evidence of long-term beneficial effects for the baby (Alfirevic et al , 2012; Likis et al , 2012). Similarly, short term, but not long-term, benefits were demonstrated in a recent network analysis of tocolytics (Haas et al , 2012).…”
Section: Introductionmentioning
confidence: 99%
“…However, we have one thing that has been shown to decrease early delivery 17-Hydroxyprogesterone Caproate (17P). The use of 17P (250 mg injected weekly) in women with a singleton pregnancy who have had a prior spontaneous early delivery, revealed a diminution in preterm births in every study (Figure 1) [5]. All of these reports showed a reduction in preterm births (<37 weeks gestation) averaging 22%.…”
Section: Introductionmentioning
confidence: 82%
“…While there is some evidence of intervention effectiveness during pregnancy on drinking (Gilinsky, Swanson, & Powers, 2011) and smoking (Lumley et al, 2009) abstinence, limited attention has been paid to the prenatal and postpartum periods. Recent reviews of postpartum home visits found no evidence of effectiveness in reducing alcohol misuse (Yonemoto, Dowswell, Nagain, & Mori, 2013) and only limited evidence for the effectiveness in promoting smoking cessation (Likis et al, 2014). However, recent success in pediatric settings of parental smoking cessation (Winickoff et al, 2013) and risky drinking interventions (Jonas et al, 2012), in concert with this study’s findings of concurrent use patterns, suggest screening for concurrent maternal smoking and alcohol consumption patterns in pediatric settings may be warranted.…”
Section: Discussionmentioning
confidence: 99%